Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...
The agency first approved Xeljanz to treat rheumatoid arthritis in 2012 and psoriatic arthritis in 2017. Now, physicians can also use the drug to treat adults with moderate-to-severe ulcerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results